## **Core Concept**
The Direct Coombs test, also known as the Direct Antiglobulin Test (DAT), is a medical test used to detect the presence of antibodies or complement proteins that are bound to the surface of red blood cells. This test is crucial in diagnosing autoimmune hemolytic anemia and other hemolytic diseases.

## **Why the Correct Answer is Right**
The Direct Coombs test detects antibodies or complement proteins that are directly attached to the surface of red blood cells. This is relevant in conditions where the immune system produces antibodies against the individual's own red blood cells, marking them for destruction. The test uses antihuman globulin (Coombs reagent) that reacts with the Fc portion of IgG antibodies or with complement components (like C3) bound to the red blood cells, causing agglutination if such antibodies or complement are present.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not accurately describe what the Direct Coombs test detects.
- **Option B:** This option is incorrect because it refers to free-floating antibodies in the plasma, which are detected by the Indirect Coombs test, not the Direct Coombs test.
- **Option C:** While this option might seem plausible, it is not the best description of what the Direct Coombs test detects.
- **Option D:** This option is incorrect because it does not accurately represent the purpose or outcome of the Direct Coombs test.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that a positive Direct Coombs test indicates that there are antibodies or complement proteins attached to the red blood cells, which can lead to their premature destruction. This is a critical diagnostic tool in investigating hemolytic anemias.

## **Correct Answer:** B. Antibodies or complement attached to RBC surface.